X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALEMBIC PHARMA AJANTA PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 21.7 26.6 81.7% View Chart
P/BV x 9.4 6.1 154.8% View Chart
Dividend Yield % 0.6 0.8 82.3%  

Financials

 AJANTA PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
ALEMBIC PHARMA
Mar-16
AJANTA PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,720792 217.3%   
Low Rs1,103443 249.0%   
Sales per share (Unadj.) Rs194.6167.0 116.5%  
Earnings per share (Unadj.) Rs45.238.2 118.5%  
Cash flow per share (Unadj.) Rs50.342.0 119.8%  
Dividends per share (Unadj.) Rs8.004.00 200.0%  
Dividend yield (eoy) %0.60.6 87.5%  
Book value per share (Unadj.) Rs132.084.9 155.5%  
Shares outstanding (eoy) m88.77188.52 47.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.33.7 196.2%   
Avg P/E ratio x31.216.2 193.0%  
P/CF ratio (eoy) x28.114.7 190.9%  
Price / Book Value ratio x10.77.3 147.0%  
Dividend payout %17.710.5 168.8%   
Avg Mkt Cap Rs m125,299116,383 107.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5704,214 61.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m17,27531,487 54.9%  
Other income Rs m16655 301.8%   
Total revenues Rs m17,44231,542 55.3%   
Gross profit Rs m5,80710,060 57.7%  
Depreciation Rs m451722 62.4%   
Interest Rs m4937 132.9%   
Profit before tax Rs m5,4749,356 58.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4602,160 67.6%   
Profit after tax Rs m4,0147,194 55.8%  
Gross profit margin %33.631.9 105.2%  
Effective tax rate %26.723.1 115.5%   
Net profit margin %23.222.8 101.7%  
BALANCE SHEET DATA
Current assets Rs m7,63915,066 50.7%   
Current liabilities Rs m2,7157,674 35.4%   
Net working cap to sales %28.523.5 121.4%  
Current ratio x2.82.0 143.3%  
Inventory Days Days4367 64.6%  
Debtors Days Days7941 193.6%  
Net fixed assets Rs m6,9148,237 83.9%   
Share capital Rs m177377 46.9%   
"Free" reserves Rs m11,44215,416 74.2%   
Net worth Rs m11,72116,005 73.2%   
Long term debt Rs m1490-   
Total assets Rs m14,81424,594 60.2%  
Interest coverage x112.9255.2 44.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.21.3 91.1%   
Return on assets %27.429.4 93.3%  
Return on equity %34.244.9 76.2%  
Return on capital %46.558.7 79.3%  
Exports to sales %55.155.7 98.9%   
Imports to sales %6.010.4 57.6%   
Exports (fob) Rs m9,52717,551 54.3%   
Imports (cif) Rs m1,0383,283 31.6%   
Fx inflow Rs m10,42217,811 58.5%   
Fx outflow Rs m1,6785,318 31.6%   
Net fx Rs m8,74412,493 70.0%   
CASH FLOW
From Operations Rs m3,2649,304 35.1%  
From Investments Rs m-2,093-3,105 67.4%  
From Financial Activity Rs m-1,186-1,959 60.5%  
Net Cashflow Rs m-154,240 -0.3%  

Share Holding

Indian Promoters % 73.8 74.1 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 2.9 53.4%  
FIIs % 7.6 9.1 83.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 13.9 122.3%  
Shareholders   20,968 49,328 42.5%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 16, 2017 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS